Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 122

1.

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis.

Angeles-Han ST, Ringold S, Beukelman T, Lovell D, Cuello CA, Becker ML, Colbert RA, Feldman BM, Holland GN, Ferguson PJ, Gewanter H, Guzman J, Horonjeff J, Nigrovic PA, Ombrello MJ, Passo MH, Stoll ML, Rabinovich CE, Sen HN, Schneider R, Halyabar O, Hays K, Shah AA, Sullivan N, Szymanski AM, Turgunbaev M, Turner A, Reston J.

Arthritis Care Res (Hoboken). 2019 Jun;71(6):703-716. doi: 10.1002/acr.23871. Epub 2019 Apr 25.

PMID:
31021540
2.

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis.

Ringold S, Angeles-Han ST, Beukelman T, Lovell D, Cuello CA, Becker ML, Colbert RA, Feldman BM, Ferguson PJ, Gewanter H, Guzman J, Horonjeff J, Nigrovic PA, Ombrello MJ, Passo MH, Stoll ML, Rabinovich CE, Schneider R, Halyabar O, Hays K, Shah AA, Sullivan N, Szymanski AM, Turgunbaev M, Turner A, Reston J.

Arthritis Rheumatol. 2019 Jun;71(6):846-863. doi: 10.1002/art.40884. Epub 2019 Apr 25.

PMID:
31021537
3.

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis.

Ringold S, Angeles-Han ST, Beukelman T, Lovell D, Cuello CA, Becker ML, Colbert RA, Feldman BM, Ferguson PJ, Gewanter H, Guzman J, Horonjeff J, Nigrovic PA, Ombrello MJ, Passo MH, Stoll ML, Rabinovich CE, Schneider R, Halyabar O, Hays K, Shah AA, Sullivan N, Szymanski AM, Turgunbaev M, Turner A, Reston J.

Arthritis Care Res (Hoboken). 2019 Jun;71(6):717-734. doi: 10.1002/acr.23870. Epub 2019 Apr 25.

PMID:
31021516
4.

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis.

Angeles-Han ST, Ringold S, Beukelman T, Lovell D, Cuello CA, Becker ML, Colbert RA, Feldman BM, Holland GN, Ferguson PJ, Gewanter H, Guzman J, Horonjeff J, Nigrovic PA, Ombrello MJ, Passo MH, Stoll ML, Rabinovich CE, Sen HN, Schneider R, Halyabar O, Hays K, Shah AA, Sullivan N, Szymanski AM, Turgunbaev M, Turner A, Reston J.

Arthritis Rheumatol. 2019 Jun;71(6):864-877. doi: 10.1002/art.40885. Epub 2019 Apr 25.

PMID:
31021511
5.

Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy.

Hinze CH, Foell D, Johnson AL, Spalding SJ, Gottlieb BS, Morris PW, Kimura Y, Onel K, Li SC, Grom AA, Taylor J, Brunner HI, Huggins JL, Nocton JJ, Haines KA, Edelheit BS, Shishov M, Jung LK, Williams CB, Tesher MS, Costanzo DM, Zemel LS, Dare JA, Passo MH, Ede KC, Olson JC, Cassidy EA, Griffin TA, Wagner-Weiner L, Weiss JE, Vogler LB, Rouster-Stevens KA, Beukelman T, Cron RQ, Kietz D, Schikler K, Mehta J, Ting TV, Verbsky JW, Eberhard AB, Huang B, Giannini EH, Lovell DJ.

Arthritis Rheumatol. 2019 Mar;71(3):451-459. doi: 10.1002/art.40727. Epub 2019 Jan 24.

6.

Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti-Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease.

Lovell DJ, Johnson AL, Huang B, Gottlieb BS, Morris PW, Kimura Y, Onel K, Li SC, Grom AA, Taylor J, Brunner HI, Huggins JL, Nocton JJ, Haines KA, Edelheit BS, Shishov M, Jung LK, Williams CB, Tesher MS, Costanzo DM, Zemel LS, Dare JA, Passo MH, Ede KC, Olson JC, Cassidy EA, Griffin TA, Wagner-Weiner L, Weiss JE, Vogler LB, Rouster-Stevens KA, Beukelman T, Cron RQ, Kietz D, Schikler K, Schmidt KM, Mehta J, Wahezi DM, Ting TV, Verbsky JW, Eberhard BA, Spalding S, Chen C, Giannini EH.

Arthritis Rheumatol. 2018 Sep;70(9):1508-1518. doi: 10.1002/art.40509. Epub 2018 Jul 25.

7.

High Levels of DEK Autoantibodies in Sera of Patients With Polyarticular Juvenile Idiopathic Arthritis and With Early Disease Flares Following Cessation of Anti-Tumor Necrosis Factor Therapy.

Mor-Vaknin N, Rivas M, Legendre M, Mohan S, Yuanfan Y, Mau T, Johnson A, Huang B, Zhao L, Kimura Y, Spalding SJ, Morris PW, Gottlieb BS, Onel K, Olson JC, Edelheit BS, Shishov M, Jung LK, Cassidy EA, Prahalad S, Passo MH, Beukelman T, Mehta J, Giannini EH, Adams BS, Lovell DJ, Markovitz DM.

Arthritis Rheumatol. 2018 Apr;70(4):594-605. doi: 10.1002/art.40404. Epub 2018 Feb 22.

8.

Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America.

Spencer CH, Rouster-Stevens K, Gewanter H, Syverson G, Modica R, Schmidt K, Emery H, Wallace C, Grevich S, Nanda K, Zhao YD, Shenoi S, Tarvin S, Hong S, Lindsley C, Weiss JE, Passo M, Ede K, Brown A, Ardalan K, Bernal W, Stoll ML, Lang B, Carrasco R, Agaiar C, Feller L, Bukulmez H, Vehe R, Kim H, Schmeling H, Gerstbacher D, Hoeltzel M, Eberhard B, Sundel R, Kim S, Huber AM, Patwardhan A; Pediatric Rheumatologist Collaborators.

Pediatr Rheumatol Online J. 2017 Jun 13;15(1):50. doi: 10.1186/s12969-017-0174-0.

9.

Methods for Developing the American College of Rheumatology's Electronic Clinical Quality Measures.

Yazdany J, Myslinski R, Miller A, Francisco M, Desai S, Schmajuk G, Lacaille D, Barber CE, Orozco C, Bunyard M, Bergman MJ, Passo M, Matteson EL, Olson R, Silverman S, Warren R, Nola K, Robbins M.

Arthritis Care Res (Hoboken). 2016 Oct;68(10):1402-9. doi: 10.1002/acr.22985. Epub 2016 Sep 16. Review. No abstract available.

10.

Identifying treatment responders and predictors of improvement after cognitive-behavioral therapy for juvenile fibromyalgia.

Sil S, Arnold LM, Lynch-Jordan A, Ting TV, Peugh J, Cunningham N, Powers SW, Lovell DJ, Hashkes PJ, Passo M, Schikler KN, Kashikar-Zuck S.

Pain. 2014 Jul;155(7):1206-12. doi: 10.1016/j.pain.2014.03.005. Epub 2014 Mar 17.

11.

Utility of the PedsQL rheumatology module as an outcome measure in juvenile fibromyalgia.

Joffe NE, Lynch-Jordan A, Ting TV, Arnold LM, Hashkes PJ, Lovell DJ, Passo MH, Powers SW, Schikler KN, Kashikar-Zuck S.

Arthritis Care Res (Hoboken). 2013 Nov;65(11):1820-7.

12.

Changes in pain coping, catastrophizing, and coping efficacy after cognitive-behavioral therapy in children and adolescents with juvenile fibromyalgia.

Kashikar-Zuck S, Sil S, Lynch-Jordan AM, Ting TV, Peugh J, Schikler KN, Hashkes PJ, Arnold LM, Passo M, Richards-Mauze MM, Powers SW, Lovell DJ.

J Pain. 2013 May;14(5):492-501. doi: 10.1016/j.jpain.2012.12.019. Epub 2013 Mar 26.

13.

Pulmonary hypertension and other potentially fatal pulmonary complications in systemic juvenile idiopathic arthritis.

Kimura Y, Weiss JE, Haroldson KL, Lee T, Punaro M, Oliveira S, Rabinovich E, Riebschleger M, Antón J, Blier PR, Gerloni V, Hazen MM, Kessler E, Onel K, Passo MH, Rennebohm RM, Wallace CA, Woo P, Wulffraat N; Childhood Arthritis Rheumatology Research Alliance Carra Net Investigators.

Arthritis Care Res (Hoboken). 2013 May;65(5):745-52. doi: 10.1002/acr.21889.

14.

Juvenile idiopathic arthritis: management and therapeutic options.

Ruth NM, Passo MH.

Ther Adv Musculoskelet Dis. 2012 Apr;4(2):99-110. doi: 10.1177/1759720X11413630.

15.

Cognitive behavioral therapy for the treatment of juvenile fibromyalgia: a multisite, single-blind, randomized, controlled clinical trial.

Kashikar-Zuck S, Ting TV, Arnold LM, Bean J, Powers SW, Graham TB, Passo MH, Schikler KN, Hashkes PJ, Spalding S, Lynch-Jordan AM, Banez G, Richards MM, Lovell DJ.

Arthritis Rheum. 2012 Jan;64(1):297-305. doi: 10.1002/art.30644.

16.

Effectiveness of dexamethasone iontophoresis for temporomandibular joint involvement in juvenile idiopathic arthritis.

Mina R, Melson P, Powell S, Rao M, Hinze C, Passo M, Graham TB, Brunner HI.

Arthritis Care Res (Hoboken). 2011 Nov;63(11):1511-6. doi: 10.1002/acr.20600.

17.

Measuring process of arthritis care: a proposed set of quality measures for the process of care in juvenile idiopathic arthritis.

Lovell DJ, Passo MH, Beukelman T, Bowyer SL, Gottlieb BS, Henrickson M, Ilowite NT, Kimura Y, DeWitt EM, Segerman J, Stein LD, Taylor J, Vehe RK, Giannini EH.

Arthritis Care Res (Hoboken). 2011 Jan;63(1):10-6. doi: 10.1002/acr.20348.

18.

Leukocyte adhesion deficiency type 1 presenting with recurrent pyoderma gangrenosum and flaccid scarring.

Hinze CH, Lucky AW, Bove KE, Marsh RA, Bleesing JH, Passo MH.

Pediatr Dermatol. 2010 Sep-Oct;27(5):500-3. doi: 10.1111/j.1525-1470.2010.01260.x. Epub 2010 Aug 27.

PMID:
20807363
19.

Controlled follow-up study of physical and psychosocial functioning of adolescents with juvenile primary fibromyalgia syndrome.

Kashikar-Zuck S, Parkins IS, Ting TV, Verkamp E, Lynch-Jordan A, Passo M, Graham TB.

Rheumatology (Oxford). 2010 Nov;49(11):2204-9. doi: 10.1093/rheumatology/keq254. Epub 2010 Aug 5.

20.

Actigraphy-based physical activity monitoring in adolescents with juvenile primary fibromyalgia syndrome.

Kashikar-Zuck S, Flowers SR, Verkamp E, Ting TV, Lynch-Jordan AM, Graham TB, Passo M, Schikler KN, Hashkes PJ, Spalding S, Banez G, Richards MM, Powers SW, Arnold LM, Lovell D.

J Pain. 2010 Sep;11(9):885-93. doi: 10.1016/j.jpain.2009.12.009. Epub 2010 Apr 24.

21.

Relationship between school absenteeism and depressive symptoms among adolescents with juvenile fibromyalgia.

Kashikar-Zuck S, Johnston M, Ting TV, Graham BT, Lynch-Jordan AM, Verkamp E, Passo M, Schikler KN, Hashkes PJ, Spalding S, Banez G, Richards MM, Powers SW, Arnold LM, Lovell D.

J Pediatr Psychol. 2010 Oct;35(9):996-1004. doi: 10.1093/jpepsy/jsq020. Epub 2010 Apr 1.

22.

Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity.

Hinze CH, Suzuki M, Klein-Gitelman M, Passo MH, Olson J, Singer NG, Haines KA, Onel K, O'Neil K, Silverman ED, Tucker L, Ying J, Devarajan P, Brunner HI.

Arthritis Rheum. 2009 Sep;60(9):2772-81. doi: 10.1002/art.24751.

23.

Educational and occupational outcomes among young adults with juvenile idiopathic arthritis.

Gerhardt CA, McGoron KD, Vannatta K, McNamara KA, Taylor J, Passo M, Noll RB.

Arthritis Rheum. 2008 Oct 15;59(10):1385-91. doi: 10.1002/art.24100.

24.

Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms.

Zhang K, Biroschak J, Glass DN, Thompson SD, Finkel T, Passo MH, Binstadt BA, Filipovich A, Grom AA.

Arthritis Rheum. 2008 Sep;58(9):2892-6. doi: 10.1002/art.23734.

25.

Anxiety, mood, and behavioral disorders among pediatric patients with juvenile fibromyalgia syndrome.

Kashikar-Zuck S, Parkins IS, Graham TB, Lynch AM, Passo M, Johnston M, Schikler KN, Hashkes PJ, Banez G, Richards MM.

Clin J Pain. 2008 Sep;24(7):620-6. doi: 10.1097/AJP.0b013e31816d7d23.

26.

Quality improvement in pediatric rheumatology: what do we need to do?

Passo MH, Taylor J.

Curr Opin Rheumatol. 2008 Sep;20(5):625-30. doi: 10.1097/BOR.0b013e32830c690f. Review.

PMID:
18698189
27.

Adherence to medications in systemic lupus erythematosus.

Koneru S, Kocharla L, Higgins GC, Ware A, Passo MH, Farhey YD, Mongey AB, Graham TB, Houk JL, Brunner HI.

J Clin Rheumatol. 2008 Aug;14(4):195-201. doi: 10.1097/RHU.0b013e31817a242a.

PMID:
18636020
28.

Preliminary validation and clinical meaning of the Cutaneous Assessment Tool in juvenile dermatomyositis.

Huber AM, Dugan EM, Lachenbruch PA, Feldman BM, Perez MD, Zemel LS, Lindsley CB, Rennebohm RM, Wallace CA, Passo MH, Reed AM, Bowyer SL, Ballinger SH, Miller FW, Rider LG; Juvenile Dermatomyositis Disease Activity Collaborative Study Group.

Arthritis Rheum. 2008 Feb 15;59(2):214-21. doi: 10.1002/art.23340.

29.

Neutrophil gelatinase-associated lipocalin as a biomarker of disease activity in pediatric lupus nephritis.

Suzuki M, Wiers KM, Klein-Gitelman MS, Haines KA, Olson J, Onel KB, O'Neil K, Passo MH, Singer NG, Tucker L, Ying J, Devarajan P, Brunner HI.

Pediatr Nephrol. 2008 Mar;23(3):403-12. doi: 10.1007/s00467-007-0685-x. Epub 2008 Jan 17.

PMID:
18202859
30.

Initial validation of the Pediatric Automated Neuropsychological Assessment Metrics for childhood-onset systemic lupus erythematosus.

Brunner HI, Ruth NM, German A, Nelson S, Passo MH, Roebuck-Spencer T, Ying J, Ris D.

Arthritis Rheum. 2007 Oct 15;57(7):1174-82.

31.

Identification of a urinary proteomic signature for lupus nephritis in children.

Suzuki M, Ross GF, Wiers K, Nelson S, Bennett M, Passo MH, Devarajan P, Brunner HI.

Pediatr Nephrol. 2007 Dec;22(12):2047-57. Epub 2007 Sep 28.

PMID:
17901988
32.

The Cutaneous Assessment Tool: development and reliability in juvenile idiopathic inflammatory myopathy.

Huber AM, Dugan EM, Lachenbruch PA, Feldman BM, Perez MD, Zemel LS, Lindsley CB, Rennebohm RM, Wallace CA, Passo MH, Reed AM, Bowyer SL, Ballinger SH, Miller FW, Rider LG; Juvenile Dermatomyositis Disease Activity Collaborative Study Group.

Rheumatology (Oxford). 2007 Oct;46(10):1606-11.

33.

Effectively measuring adherence to medications for systemic lupus erythematosus in a clinical setting.

Koneru S, Shishov M, Ware A, Farhey Y, Mongey AB, Graham TB, Passo MH, Houk JL, Higgins GC, Brunner HI.

Arthritis Rheum. 2007 Aug 15;57(6):1000-6.

34.

The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis.

Bleesing J, Prada A, Siegel DM, Villanueva J, Olson J, Ilowite NT, Brunner HI, Griffin T, Graham TB, Sherry DD, Passo MH, Ramanan AV, Filipovich A, Grom AA.

Arthritis Rheum. 2007 Mar;56(3):965-71.

35.

Cyclosporine A in juvenile idiopathic arthritis. Results of the PRCSG/PRINTO phase IV post marketing surveillance study.

Ruperto N, Ravelli A, Castell E, Gerloni V, Haefner R, Malattia C, Kanakoudi-Tsakalidou F, Nielsen S, Bohnsack J, Gibbas D, Rennebohm R, Voygioyka O, Balogh Z, Lepore L, Macejkova E, Wulffraat N, Oliveira S, Russo R, Buoncompagni A, Hilário MO, Alpigiani MG, Passo M, Lovell DJ, Merino R, Martini A, Giannini EH; Pediatric Rheumatology Collaborative Study Group (PRCSG); Paediatric Rheumatology International Trials Organisation (PRINTO).

Clin Exp Rheumatol. 2006 Sep-Oct;24(5):599-605.

PMID:
17181934
36.

The role of the clinician educator in rheumatology.

Passo MH.

Curr Rheumatol Rep. 2006 Dec;8(6):469-73. Review.

PMID:
17092445
37.

Current medication choices in juvenile rheumatoid arthritis II--update of a survey performed in 1993.

Brunner HI, Kim KN, Ballinger SH, Bowyer SL, Griffin TA, Higgins GC, Mier R, Passo MH, Rennebohm R, Schikler K, Lovell DJ.

J Clin Rheumatol. 2001 Oct;7(5):295-300.

PMID:
17039159
38.

What more can we learn from muscle histopathology in children with dermatomyositis/polymyositis?

Wargula JC, Lovell DJ, Passo MH, Bove KE, Santangelo JD, Levinson JE.

Clin Exp Rheumatol. 2006 May-Jun;24(3):333-43.

PMID:
16870106
39.

Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus.

Brunner HI, Mueller M, Rutherford C, Passo MH, Witte D, Grom A, Mishra J, Devarajan P.

Arthritis Rheum. 2006 Aug;54(8):2577-84.

40.

A randomized controlled trial of calcium supplementation to increase bone mineral density in children with juvenile rheumatoid arthritis.

Lovell DJ, Glass D, Ranz J, Kramer S, Huang B, Sierra RI, Henderson CJ, Passo M, Graham B, Bowyer S, Higgins G, Rennebohm R, Schikler KN, Giannini E.

Arthritis Rheum. 2006 Jul;54(7):2235-42.

41.

Differences in disease outcomes between medicaid and privately insured children: possible health disparities in juvenile rheumatoid arthritis.

Brunner HI, Taylor J, Britto MT, Corcoran MS, Kramer SL, Melson PG, Kotagal UR, Graham TB, Passo MH.

Arthritis Rheum. 2006 Jun 15;55(3):378-84.

42.

Disease outcomes and ovarian function of childhood-onset systemic lupus erythematosus.

Brunner HI, Bishnoi A, Barron AC, Houk LJ, Ware A, Farhey Y, Mongey AB, Strife CF, Graham TB, Passo MH.

Lupus. 2006;15(4):198-206.

PMID:
16686258
43.

Emerging therapies in juvenile rheumatoid/idiopathic arthritis.

Passo M.

Curr Probl Pediatr Adolesc Health Care. 2006 Mar;36(3):97-103. Review. No abstract available.

PMID:
16473286
44.
45.

Muscle metabolites, detected in urine by proton spectroscopy, correlate with disease damage in juvenile idiopathic inflammatory myopathies.

Chung YL, Rider LG, Bell JD, Summers RM, Zemel LS, Rennebohm RM, Passo MH, Hicks J, Miller FW, Scott DL; Juvenile Dermatomyositis Disease Activity Collaborative Study Group.

Arthritis Rheum. 2005 Aug 15;53(4):565-70.

46.

Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome.

Villanueva J, Lee S, Giannini EH, Graham TB, Passo MH, Filipovich A, Grom AA.

Arthritis Res Ther. 2005;7(1):R30-7. Epub 2004 Nov 10.

47.

Antibodies against cyclic citrullinated peptide are associated with HLA-DR4 in simplex and multiplex polyarticular-onset juvenile rheumatoid arthritis.

Ferucci ED, Majka DS, Parrish LA, Moroldo MB, Ryan M, Passo M, Thompson SD, Deane KD, Rewers M, Arend WP, Glass DN, Norris JM, Holers VM.

Arthritis Rheum. 2005 Jan;52(1):239-46.

48.

Feasibility and construct validity of the parent willingness-to-pay technique for children with juvenile idiopathic arthritis.

Barron AC, Lee TL, Taylor J, Moore T, Passo MH, Graham TB, Griffin TA, Grom AA, Lovell DJ, Brunner HI.

Arthritis Rheum. 2004 Dec 15;51(6):899-908.

49.

Lack of induction of autoantibody responses following immunization with cytomegalovirus (CMV) glycoprotein B (gB) in healthy CMV-seronegative subjects.

Schleiss MR, Bernstein DI, Passo M, Parker S, Meric C, Verdier F, Newkirk MM.

Vaccine. 2004 Dec 16;23(5):687-92.

PMID:
15542191
50.

Idiopathic hypercalcemia and eosinophilic fasciitis: a novel association.

Rutter MM, Prahalad S, Passo M, Backeljauw PF.

J Pediatr Endocrinol Metab. 2004 Sep;17(9):1251-4.

PMID:
15506687

Supplemental Content

Support Center